Compare GILT & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | PLSE |
|---|---|---|
| Founded | 1987 | 2014 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 1993 | 2016 |
| Metric | GILT | PLSE |
|---|---|---|
| Price | $15.04 | $23.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $16.00 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.1M | 359.2K |
| Earning Date | 02-10-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.22 | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $392,826,000.00 | $86,000.00 |
| Revenue This Year | $49.48 | N/A |
| Revenue Next Year | $13.61 | $1,057.59 |
| P/E Ratio | $46.69 | ★ N/A |
| Revenue Growth | ★ 29.68 | N/A |
| 52 Week Low | $5.30 | $12.56 |
| 52 Week High | $20.38 | $24.30 |
| Indicator | GILT | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 39.19 | 78.83 |
| Support Level | $17.92 | $13.59 |
| Resistance Level | $20.18 | $15.25 |
| Average True Range (ATR) | 1.20 | 1.65 |
| MACD | -0.46 | 1.16 |
| Stochastic Oscillator | 2.16 | 90.99 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.